Avid Bioservices, Inc.
DelistedCIK 704562fmd_08HXZ551C5CR23WSVD7E8GJTGNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2009 to Oct 31, 2024, 59 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 27 | 44 | 58 | 54 | 54 | 60 | 96 | 120 | 149 | 140 |
| Cost of revenue | – | 23 | 38 | 57 | 46 | 56 | 67 | 83 | 118 | 133 |
| Gross profit | 11 | 21 | 19 | (3) | 7 | 4 | 29 | 37 | 31 | 7 |
| Research and development | 43 | 60 | 28 | – | – | – | – | – | – | – |
| Selling, general and administrative | 19 | 18 | 18 | 16 | 13 | 15 | 17 | 21 | 28 | 26 |
| Total operating expenses | – | – | – | – | – | – | – | 21 | 28 | 26 |
| Operating income | (50) | 3 | 1 | (21) | (6) | (11) | 12 | 15 | 4 | (19) |
| Interest expense | 0 | – | – | – | 0 | 0 | 1 | 3 | 3 | 4 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Other non-operating income (expense) | – | – | – | – | – | – | – | (0) | 1 | (4) |
| Income before taxes | – | 4 | 1 | (21) | (5) | (10) | 11 | 13 | 2 | (27) |
| Income tax expense | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (115) | 1 | 114 |
| Net income from continuing operations | – | 4 | 1 | (21) | (5) | (10) | 11 | 128 | 0 | (141) |
| Net income | (50) | (56) | (28) | (22) | (4) | (10) | 11 | 128 | 0 | (141) |
| Net income to common shareholders | (54) | (60) | (33) | (26) | (9) | (15) | 3 | 128 | 0 | (141) |